Cleared Traditional

K191117 - NvisionVLE Low-profile Optical Probe

K191117 is the FDA 510(k) clearance for NvisionVLE Low-profile Optical Probe by Ninepoint Medical, Inc.. It is a Class 2 General & Plastic Surgery device (product code NQQ) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

K191117 · Ninepoint Medical, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2019
Decision
84d
Days
Class 2
Risk

K191117 is an FDA 510(k) clearance for the NvisionVLE Low-profile Optical Probe. Classified as System, Imaging, Optical Coherence Tomography (oct) (product code NQQ), Class II - Special Controls.

Submitted by Ninepoint Medical, Inc. (Bedford, US). The FDA issued a Cleared decision on July 19, 2019 after a review of 84 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 892.1560 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ninepoint Medical, Inc. devices

Submission Details

510(k) Number K191117 FDA.gov
FDA Decision Cleared Substantially Equivalent - Abbreviated 510(k) (SESU)
Date Received April 26, 2019
Decision Date July 19, 2019
Days to Decision 84 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
31d faster than avg
Panel avg: 115d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code NQQ System, Imaging, Optical Coherence Tomography (oct)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1560
Definition This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - NQQ System, Imaging, Optical Coherence Tomography (oct)

All 23
Devices cleared under the same product code (NQQ) and FDA review panel - the closest regulatory comparables to K191117.
OTIS 2.1 Optical Coherence Tomography System, THiA Optical Coherence Tomography System
K203578 · Perimeter Medical Imaging Ai, Inc. · Feb 2021
ApolloVue S100 Image System
K201552 · Apollo Medical Optics, Ltd. · Sep 2020
Gentuity HF-OCT Imaging System with Vis-Rx Micro-Imaging Catheter
K192922 · Gentuity, LLC · Feb 2020
Ilumien Optis, Optis Integrated, Optis Mobile
K183320 · St. Jude Medical (Now Abbott Medical) · Apr 2019
OTIS Optical Coherence Tomography SYstem
K190404 · Perimeter Medical Imaging, Inc. · Mar 2019
NvisionVLE Imaging System, NvisionVLE Optical Probe, NvisionVLE Inflation System
K182616 · Ninepoint Medical, Inc. · Nov 2018